Treatment of persistent coronavirus disease 2019 (COVID-19) in a B cell acute lymphoblastic leukemia patient with using nirmatrelvir/ritonavir extended course: A case report.
J Infect Public Health
; 17(10): 102526, 2024 Oct.
Article
em En
| MEDLINE
| ID: mdl-39226796
ABSTRACT
Patients with hematological malignancies are at increased risk of persistent coronavirus disease 2019 (COVID-19) infection, a unique clinical condition, for which the optimal treatment is unknown. Here we report a case of persistent COVID-19 in acute lymphoblastic leukemia (ALL) patient who successfully responded to extended course nirmatrelvir/ritonavir.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Ritonavir
/
COVID-19
/
Tratamento Farmacológico da COVID-19
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article